+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liposome Drug Delivery Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • PDF Icon

    Report

  • 115 Pages
  • November 2023
  • Region: Global
  • Acute Market Reports
  • ID: 5913022
Description Jump to:
The liposome drug delivery market is expected to witness a CAGR of 8.7% during the forecast period of 2023 to 2031. The liposome drug delivery is driven by advancements in drug delivery technology, especially in the context of oncology and infectious diseases. However, manufacturing challenges and the absence of standardization remain significant restraints. The industry is poised for further innovation with evolving liposome structures and product development. North America is projected to lead in terms of CAGR, while Asia-Pacific will continue to dominate in revenue. The future of this market is promising as it addresses unmet medical needs and continues to drive innovation in drug delivery systems to enhance therapeutic outcomes and patient care.

Advancements in Drug Delivery Technology

A key driver for the Liposome Drug Delivery market is the continuous advancement in drug delivery technology. Liposomes have gained attention as a drug delivery system due to their ability to encapsulate both hydrophilic and hydrophobic drugs, allowing targeted and sustained release. Recent developments in liposome formulations, including pegylation and surface modification, have improved drug bioavailability and reduced side effects. This is evidenced by the increasing number of liposomal drug approvals by regulatory agencies, signaling their effectiveness and the pharmaceutical industry's growing interest in this technology.

Growing Oncology Applications

The growth of liposomal drug delivery is prominently driven by its expanding applications in oncology. Liposomal formulations of chemotherapeutic agents like Doxorubicin and Paclitaxel have demonstrated enhanced efficacy and reduced toxicity, making them valuable in the treatment of various cancers. The growing incidence of cancer and the need for more effective and less toxic treatments have led to the increased adoption of liposomal drug delivery in oncology. This trend is reflected in the expanding range of liposomal anticancer drugs and the high revenue generated in this segment.

Increasing Prevalence of Infectious Diseases

Liposomes have found substantial applications in addressing infectious diseases. In particular, Liposomal Amphotericin B is a breakthrough in treating fungal and parasitic infections, with higher safety and efficacy compared to conventional formulations. The rise in infectious diseases, particularly in tropical regions, has led to a growing demand for liposomal drug delivery systems to combat these infections effectively. This is evidenced by the rising number of cases and research studies on liposomal drug delivery for infectious diseases.

Challenges in Manufacturing and Standardization

A significant restraint in the Liposome Drug Delivery market is the challenges associated with manufacturing and standardization. The production of liposomal drug formulations requires precision in size, composition, and encapsulation, which can be technically demanding. Ensuring batch-to-batch consistency and product quality remains a challenge. The absence of standardized manufacturing processes may lead to variations in liposome drug products, impacting their efficacy and safety. This restraint is observed in reported instances of manufacturing variability and the need for regulatory guidelines to standardize liposome drug production.

Liposome Structure: Multilamellar Liposomes Dominate the Market

In 2022, the Liposome Drug Delivery market featured various liposome structures, with multilamellar liposomes generating significant revenue due to their ability to encapsulate a wide range of drugs. However, during the forecast period from 2023 to 2031, the highest Compound Annual Growth Rate (CAGR) is anticipated in the others category. Innovative liposome structures and formulations are expected to drive this growth as researchers explore new ways to optimize drug delivery and bioavailability.

Product: Liposomal Doxorubicin Dominates the Market

In 2022, the Liposomal Doxorubicin segment generated substantial revenue due to its established applications in oncology. However, during the forecast period from 2023 to 2031, the highest CAGR is expected in the Liposomal Paclitaxel segment, driven by its growing adoption in cancer treatment. The development of new liposomal drug products is likely to bolster the growth of the others segment, underscoring the dynamism of this market.

APAC Remains as the Global Leader

During the forecast period from 2023 to 2031, North America is expected to exhibit the highest CAGR in the Liposome Drug Delivery market. This growth can be attributed to the region's advanced healthcare infrastructure and robust R&D activities. Asia-Pacific, with its expanding pharmaceutical sector, is anticipated to maintain the highest revenue percentage during the same period, particularly in the oncology and infectious disease treatment segments.

Market Competition to Intensify during the Forecast Period

In 2022, the Liposome Drug Delivery market was characterized by several key players, including pharmaceutical companies specializing in liposomal drug formulations. These companies are expected to maintain their dominant positions during the forecast period from 2023 to 2031. Key strategies for industry leaders will revolve around product innovation, expanding liposomal drug portfolios, and global market expansion to cater to the increasing demand for advanced drug delivery systems.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofLiposome Drug Delivery market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Liposome Drug Delivery market and their expected impact during the forecast period
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Liposome Structure

  • Unilamellar Liposomes
  • Multilamellar Liposomes
  • Others

Product

  • Liposomal Doxorubicin
  • Liposomal Paclitaxel
  • Liposomal Amphotericin B
  • Others

Technology

  • Stealth Liposome Technology
  • Non-PEGylated Liposome Technology
  • DepoFoam Liposome Technology

Application

  • Fungal Diseases
  • Pain Management
  • Cancer Therapy
  • Viral Vaccines
  • Photodynamic therapy

End-User

  • Hospitals
  • Specialty Centers
  • Ambulatory Surgical Centers
  • Others

Region Segment (2021 - 2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Liposome Drug Delivery market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Liposome Drug Delivery market?
  • Which is the largest regional market for Liposome Drug Delivery market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Liposome Drug Delivery market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Liposome Drug Delivery market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Liposome Drug Delivery Market
2.2. Global Liposome Drug Delivery Market, By Liposome Structure, 2022 (US$ Million)
2.3. Global Liposome Drug Delivery Market, By Product, 2022 (US$ Million)
2.4. Global Liposome Drug Delivery Market, By Technology, 2022 (US$ Million)
2.5. Global Liposome Drug Delivery Market, By Application, 2022 (US$ Million)
2.6. Global Liposome Drug Delivery Market, By End-User, 2022 (US$ Million)
2.7. Global Liposome Drug Delivery Market, By Geography, 2022 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2022
3. Liposome Drug Delivery Market: Competitive Analysis
3.1. Market Positioning of Key Liposome Drug Delivery Market Vendors
3.2. Strategies Adopted by Liposome Drug Delivery Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Liposome Drug Delivery Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Liposome Drug Delivery Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter’s Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Unilamellar Liposomes
5.3.1.1. Small
5.3.1.2. Large
5.3.2. Multilamellar Liposomes
5.3.3. Others
6. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Liposomal Doxorubicin
6.3.2. Liposomal Paclitaxel
6.3.3. Liposomal Amphotericin B
6.3.4. Others
7. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
7.3.1. Stealth Liposome Technology
7.3.2. Non-PEGylated Liposome Technology
7.3.3. DepoFoam Liposome Technology
8. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2022 Versus 2031
8.3. Market Segmentation
8.3.1. Fungal Diseases
8.3.2. Pain Management
8.3.3. Cancer Therapy
8.3.4. Viral Vaccines
8.3.5. Photodynamic therapy
9. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Growth & Revenue Analysis: 2022 Versus 2031
9.3. Market Segmentation
9.3.1. Hospitals
9.3.2. Specialty Centers
9.3.3. Ambulatory Surgical Centers
9.3.4. Others
10. North America Liposome Drug Delivery Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
10.3. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
10.4. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
10.5. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
10.6. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
10.7. Liposome Drug Delivery Market: By Region, 2021-2031, USD (Million)
10.7.1. North America
10.7.1.1. U.S.
10.7.1.1.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
10.7.1.1.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
10.7.1.1.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
10.7.1.1.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
10.7.1.1.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
10.7.1.2. Canada
10.7.1.2.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
10.7.1.2.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
10.7.1.2.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
10.7.1.2.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
10.7.1.2.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
10.7.1.3. Rest of North America
10.7.1.3.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
10.7.1.3.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
10.7.1.3.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
10.7.1.3.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
10.7.1.3.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
11. UK and European Union Liposome Drug Delivery Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
11.3. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
11.4. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
11.5. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
11.6. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
11.7. Liposome Drug Delivery Market: By Region, 2021-2031, USD (Million)
11.7.1. UK and European Union
11.7.1.1. UK
11.7.1.1.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
11.7.1.1.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
11.7.1.1.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
11.7.1.1.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
11.7.1.1.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
11.7.1.2. Germany
11.7.1.2.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
11.7.1.2.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
11.7.1.2.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
11.7.1.2.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
11.7.1.2.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
11.7.1.3. Spain
11.7.1.3.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
11.7.1.3.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
11.7.1.3.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
11.7.1.3.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
11.7.1.3.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
11.7.1.4. Italy
11.7.1.4.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
11.7.1.4.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
11.7.1.4.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
11.7.1.4.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
11.7.1.4.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
11.7.1.5. France
11.7.1.5.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
11.7.1.5.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
11.7.1.5.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
11.7.1.5.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
11.7.1.5.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
11.7.1.6. Rest of Europe
11.7.1.6.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
11.7.1.6.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
11.7.1.6.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
11.7.1.6.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
11.7.1.6.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
12. Asia Pacific Liposome Drug Delivery Market, 2021-2031, USD (Million)
12.1. Market Overview
12.2. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
12.3. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
12.4. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
12.5. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
12.6. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
12.7. Liposome Drug Delivery Market: By Region, 2021-2031, USD (Million)
12.7.1. Asia Pacific
12.7.1.1. China
12.7.1.1.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
12.7.1.1.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
12.7.1.1.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
12.7.1.1.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
12.7.1.1.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
12.7.1.2. Japan
12.7.1.2.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
12.7.1.2.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
12.7.1.2.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
12.7.1.2.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
12.7.1.2.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
12.7.1.3. India
12.7.1.3.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
12.7.1.3.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
12.7.1.3.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
12.7.1.3.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
12.7.1.3.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
12.7.1.4. Australia
12.7.1.4.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
12.7.1.4.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
12.7.1.4.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
12.7.1.4.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
12.7.1.4.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
12.7.1.5. South Korea
12.7.1.5.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
12.7.1.5.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
12.7.1.5.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
12.7.1.5.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
12.7.1.5.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
12.7.1.6. Rest of Asia Pacific
12.7.1.6.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
12.7.1.6.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
12.7.1.6.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
12.7.1.6.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
12.7.1.6.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
13. Latin America Liposome Drug Delivery Market, 2021-2031, USD (Million)
13.1. Market Overview
13.2. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
13.3. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
13.4. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
13.5. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
13.6. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
13.7. Liposome Drug Delivery Market: By Region, 2021-2031, USD (Million)
13.7.1. Latin America
13.7.1.1. Brazil
13.7.1.1.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
13.7.1.1.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
13.7.1.1.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
13.7.1.1.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
13.7.1.1.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
13.7.1.2. Mexico
13.7.1.2.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
13.7.1.2.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
13.7.1.2.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
13.7.1.2.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
13.7.1.2.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
13.7.1.3. Rest of Latin America
13.7.1.3.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
13.7.1.3.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
13.7.1.3.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
13.7.1.3.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
13.7.1.3.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
14. Middle East and Africa Liposome Drug Delivery Market, 2021-2031, USD (Million)
14.1. Market Overview
14.2. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
14.3. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
14.4. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
14.5. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
14.6. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
14.7. Liposome Drug Delivery Market: By Region, 2021-2031, USD (Million)
14.7.1. Middle East and Africa
14.7.1.1. GCC
14.7.1.1.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
14.7.1.1.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
14.7.1.1.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
14.7.1.1.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
14.7.1.1.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
14.7.1.2. Africa
14.7.1.2.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
14.7.1.2.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
14.7.1.2.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
14.7.1.2.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
14.7.1.2.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
14.7.1.3. Rest of Middle East and Africa
14.7.1.3.1. Liposome Drug Delivery Market: By Liposome Structure, 2021-2031, USD (Million)
14.7.1.3.2. Liposome Drug Delivery Market: By Product, 2021-2031, USD (Million)
14.7.1.3.3. Liposome Drug Delivery Market: By Technology, 2021-2031, USD (Million)
14.7.1.3.4. Liposome Drug Delivery Market: By Application, 2021-2031, USD (Million)
14.7.1.3.5. Liposome Drug Delivery Market: By End-User, 2021-2031, USD (Million)
15. Company Profile
15.1. Johnson & Johnson Services, Inc.
15.1.1. Company Overview
15.1.2. Financial Performance
15.1.3. Product Portfolio
15.1.4. Strategic Initiatives
15.2. Gilead Sciences, Inc.
15.2.1. Company Overview
15.2.2. Financial Performance
15.2.3. Product Portfolio
15.2.4. Strategic Initiatives
15.3. Sun Pharmaceutical Industries Ltd.
15.3.1. Company Overview
15.3.2. Financial Performance
15.3.3. Product Portfolio
15.3.4. Strategic Initiatives
15.4. Novartis AG
15.4.1. Company Overview
15.4.2. Financial Performance
15.4.3. Product Portfolio
15.4.4. Strategic Initiatives
15.5. Teva Pharmaceutical Industries Ltd.
15.5.1. Company Overview
15.5.2. Financial Performance
15.5.3. Product Portfolio
15.5.4. Strategic Initiatives
15.6. Janssen Pharmaceuticals, Inc.
15.6.1. Company Overview
15.6.2. Financial Performance
15.6.3. Product Portfolio
15.6.4. Strategic Initiatives
15.7. CELSION Corporation
15.7.1. Company Overview
15.7.2. Financial Performance
15.7.3. Product Portfolio
15.7.4. Strategic Initiatives
15.8. Abbott
15.8.1. Company Overview
15.8.2. Financial Performance
15.8.3. Product Portfolio
15.8.4. Strategic Initiatives
15.9. Ipsen Pharma
15.9.1. Company Overview
15.9.2. Financial Performance
15.9.3. Product Portfolio
15.9.4. Strategic Initiatives
15.10. Spectrum Pharmaceuticals, Inc.
15.10.1. Company Overview
15.10.2. Financial Performance
15.10.3. Product Portfolio
15.10.4. Strategic Initiatives
15.11. Takeda Pharmaceutical Company Limited
15.11.1. Company Overview
15.11.2. Financial Performance
15.11.3. Product Portfolio
15.11.4. Strategic Initiatives
15.12. Other Notable Players
15.12.1. Company Overview
15.12.2. Financial Performance
15.12.3. Product Portfolio
15.12.4. Strategic Initiatives
List of Figures
Fig. 1 Global Liposome Drug Delivery Market: Market Coverage
Fig. 2 Research Methodology and Data Sources
Fig. 3 Market Size Estimation-Top Down & Bottom-Up Approach
Fig. 4 Global Liposome Drug Delivery Market: Quality Assurance
Fig. 5 Global Liposome Drug Delivery Market, By Liposome Structure, 2022
Fig. 6 Global Liposome Drug Delivery Market, By Product, 2022
Fig. 7 Global Liposome Drug Delivery Market, By Technology, 2022
Fig. 8 Global Liposome Drug Delivery Market, By Application, 2022
Fig. 9 Global Liposome Drug Delivery Market, By End-User, 2022
Fig. 10 Global Liposome Drug Delivery Market, By Geography, 2022
Fig. 11 Market Geographical Opportunity Matrix-Global Liposome Drug Delivery Market, 2022
Fig. 12 Market Positioning of Key Liposome Drug Delivery Market Players, 2022
Fig. 13 Global Liposome Drug Delivery Market-Tier Analysis-Percentage of Revenues by Tier Level, 2022 Versus 2031
Fig. 14 Global Liposome Drug Delivery Market, By Liposome Structure, 2022 Vs 2031, %
Fig. 15 Global Liposome Drug Delivery Market, By Product, 2022 Vs 2031, %
Fig. 16 Global Liposome Drug Delivery Market, By Technology, 2022 Vs 2031, %
Fig. 17 Global Liposome Drug Delivery Market, By Application, 2022 Vs 2031, %
Fig. 18 Global Liposome Drug Delivery Market, By End-User, 2022 Vs 2031, %
Fig. 19 U.S. Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 20 Canada Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 21 Rest of North America Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 22 UK Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 23 Germany Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 24 Spain Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 25 Italy Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 26 France Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 27 Rest of Europe Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 28 China Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 29 Japan Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 30 India Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 31 Australia Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 32 South Korea Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 33 Rest of Asia Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 34 Brazil Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 35 Mexico Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 36 Rest of Latin America Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 37 GCC Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 38 Africa Liposome Drug Delivery Market (US$ Million), 2021-2031
Fig. 39 Rest of Middle East and Africa Liposome Drug Delivery Market (US$ Million), 2021-2031
List of Tables
Table 1 Global Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 2 Global Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 3 Global Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 4 Global Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 5 Global Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 6 Global Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 7 North America Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 8 North America Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 9 North America Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 10 North America Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 11 North America Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 12 North America Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 13 U.S. Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 14 U.S. Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 15 U.S. Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 16 U.S. Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 17 U.S. Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 18 U.S. Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 19 Canada Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 20 Canada Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 21 Canada Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 22 Canada Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 23 Canada Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 24 Canada Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 25 Rest of North America Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 26 Rest of North America Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 27 Rest of North America Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 28 Rest of North America Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 29 Rest of North America Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 30 Rest of North America Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 31 UK and European Union Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 32 UK and European Union Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 33 UK and European Union Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 34 UK and European Union Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 35 UK and European Union Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 36 UK and European Union Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 37 UK Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 38 UK Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 39 UK Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 40 UK Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 41 UK Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 42 UK Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 43 Germany Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 44 Germany Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 45 Germany Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 46 Germany Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 47 Germany Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 48 Germany Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 49 Spain Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 50 Spain Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 51 Spain Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 52 Spain Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 53 Spain Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 54 Spain Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 55 Italy Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 56 Italy Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 57 Italy Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 58 Italy Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 59 Italy Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 60 Italy Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 61 France Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 62 France Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 63 France Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 64 France Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 65 France Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 66 France Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 67 Rest of Europe Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 68 Rest of Europe Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 69 Rest of Europe Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 70 Rest of Europe Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 71 Rest of Europe Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 72 Rest of Europe Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 73 Asia Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 74 Asia Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 75 Asia Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 76 Asia Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 77 Asia Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 78 Asia Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 79 China Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 80 China Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 81 China Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 82 China Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 83 China Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 84 China Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 85 Japan Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 86 Japan Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 87 Japan Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 88 Japan Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 89 Japan Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 90 Japan Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 91 India Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 92 India Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 93 India Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 94 India Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 95 India Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 96 India Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 97 Australia Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 98 Australia Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 99 Australia Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 100 Australia Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 101 Australia Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 102 Australia Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 103 South Korea Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 104 South Korea Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 105 South Korea Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 106 South Korea Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 107 South Korea Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 108 South Korea Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 109 Latin America Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 110 Latin America Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 111 Latin America Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 112 Latin America Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 113 Latin America Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 114 Latin America Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 115 Brazil Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 116 Brazil Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 117 Brazil Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 118 Brazil Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 119 Brazil Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 120 Brazil Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 121 Mexico Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 122 Mexico Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 123 Mexico Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 124 Mexico Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 125 Mexico Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 126 Mexico Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 127 Rest of Latin America Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 128 Rest of Latin America Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 129 Rest of Latin America Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 130 Rest of Latin America Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 131 Rest of Latin America Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 132 Rest of Latin America Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 133 Middle East and Africa Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 134 Middle East and Africa Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 135 Middle East and Africa Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 136 Middle East and Africa Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 137 Middle East and Africa Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 138 Middle East and Africa Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 139 GCC Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 140 GCC Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 141 GCC Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 142 GCC Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 143 GCC Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 144 GCC Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 145 Africa Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 146 Africa Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 147 Africa Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 148 Africa Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 149 Africa Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 150 Africa Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)
Table 151 Rest of Middle East and Africa Liposome Drug Delivery Market By Liposome Structure, 2021-2031, USD (Million)
Table 152 Rest of Middle East and Africa Liposome Drug Delivery Market By Unilamellar Liposomes, 2021-2031, USD (Million)
Table 153 Rest of Middle East and Africa Liposome Drug Delivery Market By Product, 2021-2031, USD (Million)
Table 154 Rest of Middle East and Africa Liposome Drug Delivery Market By Technology, 2021-2031, USD (Million)
Table 155 Rest of Middle East and Africa Liposome Drug Delivery Market By Application, 2021-2031, USD (Million)
Table 156 Rest of Middle East and Africa Liposome Drug Delivery Market By End-User, 2021-2031, USD (Million)

Companies Mentioned

  • Johnson & Johnson Services, Inc.
  • Gilead Sciences, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Janssen Pharmaceuticals, Inc.
  • CELSION Corporation
  • Abbott
  • Ipsen Pharma
  • Spectrum Pharmaceu

Related Topics

Related Reports

Liposomes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Liposomes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 201 Pages
  • Global
From
Liposome Drug Delivery - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Liposome Drug Delivery - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 111 Pages
  • Global
From
Targeted Liposomes Drug Delivery Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Targeted Liposomes Drug Delivery Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Liposome Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Liposome Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 91 Pages
  • Global
From
Hydrogels in Drug Delivery. Advances in the Manufacture, Characterization, and Application of Hydrogels to Address Current Global Healthcare Challenges - Product Image

Hydrogels in Drug Delivery. Advances in the Manufacture, Characterization, and Application of Hydrogels to Address Current Global Healthcare Challenges

  • Book
  • Global
Copyright © 2002-2024 Research and Markets. All Rights Reserved.